Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

2.02
-0.0400-1.94%
Post-market: 2.00-0.0200-0.99%19:12 EDT
Volume:1.55M
Turnover:3.09M
Market Cap:363.60M
PE:-18.25
High:2.05
Open:2.02
Low:1.93
Close:2.06
52wk High:3.04
52wk Low:0.3418
Shares:180.00M
Float Shares:112.00M
Volume Ratio:0.61
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1107
EPS(LYR):-0.1107
ROE:-5.98%
ROA:-3.26%
PB:2.29
PE(LYR):-18.25

Loading ...

Century Therapeutics Shares Fall After Leerink Partners Downgrade

MT Newswires Live
·
Nov 18, 2025

Century Therapeutics (IPSC) Gets a Buy from Clear Street

TIPRANKS
·
Nov 17, 2025

Leerink Partners Downgrades Century Therapeutics to Market Perform From Outperform

MT Newswires Live
·
Nov 17, 2025

Century Therapeutics Q3 net loss widens, despite lower costs

Reuters
·
Nov 13, 2025

Century Therapeutics reports Q3 EPS (40c) vs (37c) last year

TIPRANKS
·
Nov 13, 2025

Century Therapeutics Q3 EPS $(0.40) Misses $(0.34) Estimate

Benzinga
·
Nov 13, 2025

BRIEF-Century Therapeutics Q3 Net Income USD -34.422 Million

Reuters
·
Nov 13, 2025

Century Therapeutics Q3 Operating Income USD -36.124 Million

THOMSON REUTERS
·
Nov 13, 2025

Century Therapeutics Inc - Estimates Cash Runway Into 4Q 2027

THOMSON REUTERS
·
Nov 13, 2025

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 13, 2025

Century Therapeutics Reports Preclinical Success for Immune-Evasive Beta Islet Therapy in Type 1 Diabetes

Reuters
·
Nov 13, 2025

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

THOMSON REUTERS
·
Nov 13, 2025

Century Therapeutics Inc - Ind-Enabling Studies to Start by Year-End 2025, Ind Submission Planned as Early as 2026

THOMSON REUTERS
·
Nov 13, 2025

Top News Today/Canada: Barrick's Interim CEO Gets to Work

Dow Jones
·
Nov 11, 2025

Century Therapeutics’ CALiPSO-1 Study: A Promising Step in Autoimmune Disease Treatment

TIPRANKS
·
Oct 28, 2025

Century Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
Oct 24, 2025

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

GlobeNewswire
·
Oct 15, 2025